Clinical & Diagnostic

Verantos' AI Advancement in Neurology Bolstered by Groundbreaking Migraine Real-World Evidence

Technology enables inference of subjective outcomes from routinely collected data...

Vial Enrolls First Patient in "OcuCool" Precision Cooling Trial Sponsored by RecensMedical

Vial, a leading global contract research organization (CRO) providing next-generation clinical trial management services, announced the enrollment of the first patient in the pivotal clinical trial, "COOL-3s", evaluating the OcuCool system, developed by RecensMedical, Inc. ("RecensMedical"), a distinguished medical device company based in South Korea. ...

Hackensack Meridian JFK University Medical Center Performs First Robotic Surgery with Heated Chemotherapy for Malignant Thymoma

Surgeons in the Division of Thoracic Surgery at JFK University Medical Center first in the State of New Jersey to perform this surgery...

Improved Access to Alzheimer's Blood Test Through Beckman Coulter-Fujirebio Partnership

Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter’s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay Analyzers...

Devyser's NGS Products for Kidney Transplants Get IVDR Approvals

Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe. These tests are the first post-transplant monitoring NGS products to be approved under the new, more comprehensive regulation that came into force in May 2022 and confirm Devyser's two NGS products meet the established safety, efficacy, and quality requirements....

Optina's REPHRASE Study Validates Innovative Alzheimer's Test

Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....

Kidney Patients Expand Worldwide Impact on Medical Innovations

Patient-Led Global Summit on Science, Policy, and Care Choice Drives Optimism...

Aster DM Healthcare Successfully Rebrands Ramesh Hospitals to Aster Ramesh Hospitals

Affirms Strong Performance and Focus on India Amidst Ongoing Expansion...

Yashoda Hospital, Kaushambi forays into genomic testing in collaboration with HaystackAnalytics

Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan ...